Vertex Securities Ltd

{"rightRatio":"1:1"}

{"description":"Vertex Pharmaceuticals received FDA Breakthrough Therapy Designation for povetacicept, targeting IgA nephropathy. This designation may expedite development and review, potentially improving patient access and positively impacting Vertex's stock and market position.","url":"https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-fda-breakthrough-135410363.html","sentiment":"Positive","domain":"Yahoo Finance"}